Substances known to be myotoxic are reviewed, including descriptions of the
resultant clinical syndromes and the mechanisms important in their develop
ment. Certain host characteristics such as altered immune and metabolic reg
ulation are known to modulate the effects of individual myotoxins, producin
g varied clinical syn dromes. Evaluation procedures important in identifyin
g a toxin-induced myopathy are described.